NEW YORK, April 12, 2006 (PRIMEZONE) -- Seeger Weiss LLP announces that it is investigating claims against Merck & Co. (NYSE:MRK) for Fosamax-related injuries, including reports of osteonecrosis of the jaw. Fosamax, marketed by Merck, is indicated for the treatment and prevention of osteoporosis (thinning of the bones) in men and women. Recent studies, however, suggest a link between the use of bisphosphonates, such as Fosamax, and osteonecrosis of the jaw, also known as "jaw death." This condition is associated with the interference of the blood supply to the bone and the consequential damage that occurs. Osteonecrosis of the jaw can be extremely painful and may lead to additional complications, such as infection, breakdown of the jawbone, and ulcerations in the lining of the mouth. It is not known if ceasing the use of Fosamax can lower the risk of osteonecrosis of the jaw, as the bisphosphonate medications metabolize slowly and remain in the bones for many years. If you have taken Fosamax and experienced any of the aforementioned side-effects, please visit http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Fosamax-P76/ or call (877) 541-3273 to request a free evaluation.
About Seeger Weiss LLP
Seeger Weiss (www.seegerweiss.com) is a New York based law firm that is active in major complex litigations, including pharmaceutical mass tort and product defect cases pending in federal and state courts throughout the United States. Seeger Weiss has taken a leading role in many important actions on behalf of injured consumers and has successfully recovered millions of dollars for individual clients and class members. For example, Seeger Weiss currently serves as Court Appointed Co-Lead Counsel in the federal Vioxx Litigation (http://www.seegerweiss.com/cases/Cases.aspx?ID=24) and was one of the lead firms that negotiated the recently announced $700 million settlement of claims on behalf of individuals who were injured as a result of their use of the prescription drug Zyprexa (http://www.seegerweiss.com/cases/Cases.aspx?ID=27).
If you or a family member is using or has used Fosamax and would like to discuss your rights, or if you have information concerning the potential adverse consequences associated with the use of Fosamax that you would like to share with us, please contact us:
Christopher A. Seeger, Esq. http://www.lawyerseek.com/Attorneys/Christopher-A-Seeger-Partners-E3.html David R. Buchanan, Esq. http://www.lawyerseek.com/Attorneys/David-R-Buchanan-Partners-E6.html Seeger Weiss LLP One William Street New York, New York 10004 E-Mail: cseeger@seegerweiss.com dbuchanan@seegerweiss.com Tel: (212) 584-0700 Toll Free: (877) 541-3273 www.seegerweiss.com, www.lawyerseek.com
To submit a claim for review please visit:http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Fosamax-P76/